Research Article

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii

Table 1

Antibiotic Susceptibility Testing for Acinetobacter baumannii.

Antimicrobial agentAcinetobacter baumannii
A1A2A3A4A5
(mm)S-I-R (mm)S-I-R (mm)S-I-R (mm)S-I-R (mm)S-I-R

Imipenem 19S6R9R6R9R
Meropenem 19S6R8R9R8R
Cefotaxime 6R6R6R21I6R
Ceftazidime 6R6R6R28S6R
Cefepime 6R6R6R28S6R
Ertapenem 11R6R6R6R6R
Gentamycin 7R6R6R31S9R
Cefuroxime 6R6R6R6R6R
Cefoxitin 6R12R12R6R15R
Ciprofloxacin 6R6R6R29S9R
Amoxicillin + clavulanic acid6R6R6R7R6R
Tigecycline17S19S19S21S19S
Tobramycin 16S11R10R25S10R
Amikacin 16I13R10R32S11R
Trimethoprim Sulfamethoxazole 6R6R6R21S6R
Ampicillin 6R6R6R6R6R

“S” stands for susceptible, “I” for intermediate resistance, and “R” for resistant. “” stands for diameter of inhibition zone. A1 through A5 represent the 5 Acinetobacter baumannii strains studied. The test was done according to CLSI guidelines.